LLC Wholesale installs cloud-based systems for Drug Quality and Security Act (DQSA) compliance
The passage of the Drug Quality and Security Act (DQSA) last November is a signal event in pharmaceutical distribution: now, the first steps toward tracking drug shipments throughout supply chains, nationally, are a matter of law. One of the first new implementations since DQSA was passed has been announced by International Business Systems (IBS; Solna, Sweden; US HQ in Folsom, CA) for a regional wholesaler, LLC Wholesale Supply (Tempe, AZ), which calls itself a full-service distributor and wholesaler of branded and generic pharmaceuticals, med-surg and durable medical equipment.
IBS is installing its Enterprise system, part of the Business Suite 2014 which it characterizes as a mid-market enterprise resource-planning platform. A version of Enterprise is tailored to the specific needs of pharma manufacturers and distributors, coming pre-built with capabilities for handling rebates, controlled substances (the DEA-approved Controlled Substances Ordering System, or CSOS), distributor-license validation and others common to pharma distribution. It also manages drug NDC numbers, an element of DQSA compliance. The Enterprise product is managed as a cloud-based system, operating from an IBS data center. Michael O’Brian, VP Americas for the firm, says that the implementations should be complete by June 1.
Another part of the implementation will be the integration of the cloud-based ePedigree Management solution from rfXcel (San Ramon, CA), a longtime player in the serialization/track-and-trace space that is partnering with IBS. As Glenn Abood, CEO of the firm, explains, although California’s e-Pedigree rules are a thing of the past, clients like LLC Wholesale can take advantage of the ePedigree Management systems capability to receive, store, update and report out transaction events during supply chain activity (such as order processing, shipment notifications and the like)—all the things that will eventually be part of compliance with DQSA. Abood says that his company has kept close track of, and participates in, the standards-setting in traceability going on at the GS1 organization. “Some of our clients are already seeing the benefits of better supply chain visibility in handling recalls, for example; many of the things that were promised all along in the serialization debates.”
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.